Karzoon, A. Et Al. 2024. Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.. Naunyn-Schmiedeberg's archives of pharmacology .

Karzoon, A., Yerer, M. B., & Cumaoğlu, A., (2024). Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.. Naunyn-Schmiedeberg's archives of pharmacology .

Karzoon, Ahmad, MÜKERREM BETÜL AYCAN, And AHMET CUMAOĞLU. "Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.," Naunyn-Schmiedeberg's archives of pharmacology , 2024

Karzoon, Ahmad Et Al. "Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.." Naunyn-Schmiedeberg's archives of pharmacology , 2024

Karzoon, A. Yerer, M. B. And Cumaoğlu, A. (2024) . "Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.." Naunyn-Schmiedeberg's archives of pharmacology .

@article{article, author={Ahmad Karzoon Et Al. }, title={Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.}, journal={Naunyn-Schmiedeberg's archives of pharmacology}, year=2024}